Previous reports demonstrated that altered regulation of TP53 can lead to various neurological/psychological disorders such as Alzheimer’s disease, schizophrenia, and encephalopathy (58–60). Here, TP53 is linked to early-onset autosomal dominant Alzheimer disease.